Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ANPA-0073 by Schrodinger for Pulmonary Arterial Hypertension: Likelihood of Approval
ANPA-0073 is under clinical development by Schrodinger and currently in Phase I for Pulmonary Arterial Hypertension. According to GlobalData, Phase...
ANPA-0073 by Schrodinger for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
ANPA-0073 is under clinical development by Schrodinger and currently in Phase I for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase...
SGR-3515 by Schrodinger for Solid Tumor: Likelihood of Approval
SGR-3515 is under clinical development by Schrodinger and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
SGR-1505 by Schrodinger for Splenic Marginal Zone B-Cell Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Splenic Marginal Zone B-Cell Lymphoma. According to...
SGR-1505 by Schrodinger for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Primary Mediastinal B-Cell Lymphoma. According to GlobalData,...
SGR-1505 by Schrodinger for Refractory Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Refractory Chronic Lymphocytic Leukemia (CLL). According to...
SGR-1505 by Schrodinger for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Relapsed Chronic Lymphocytic Leukemia (CLL). According to...
SGR-1505 by Schrodinger for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma): Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma). According to GlobalData,...
SGR-1505 by Schrodinger for Follicular Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase I...
SGR-1505 by Schrodinger for Burkitt Lymphoma: Likelihood of Approval
SGR-1505 is under clinical development by Schrodinger and currently in Phase I for Burkitt Lymphoma. According to GlobalData, Phase I...
SGR-2921 by Schrodinger for Myelodysplastic Syndrome: Likelihood of Approval
SGR-2921 is under clinical development by Schrodinger and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData, Phase I...
SGR-2921 by Schrodinger for Refractory Acute Myeloid Leukemia: Likelihood of Approval
SGR-2921 is under clinical development by Schrodinger and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData,...
SGR-2921 by Schrodinger for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
SGR-2921 is under clinical development by Schrodinger and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to GlobalData,...